Historic Marijuana Rescheduling: What It Does & Does Not Mean for Your Financial Institution.

It just got more complicated. Get clear on what actually changed, what did not, and what your institution needs to do next before the regulators do it for you.

In April 2026, the long-awaited reclassification of marijuana from a Schedule 1 drug (on par with heroin) to a Schedule 3 drug (comparable to Tylenol® with codeine) was announced by the Department of Justice. The historic rescheduling of medical marijuana will favorably impact the cannabis industry — and potentially could improve licensed marijuana operators’ access to financial institutions’ products and services. This webinar will explore how to assess and manage risks associated with providing products and services to the cannabis industry post-rescheduling and pre-SAFER Banking Act. Learn what rescheduling means (or does not mean) for your financial institution’s marijuana policy, testing, terminations, accommodations, and other HR and business issues.